{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T06:13:41Z","timestamp":1793168021724,"version":"4.5.0"},"reference-count":12,"publisher":"SAGE Publications","issue":"6","license":[{"start":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T00:00:00Z","timestamp":1726012800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of VitreoRetinal Diseases"],"published-print":{"date-parts":[[2024,11]]},"abstract":"<jats:p>Purpose: To analyze the outcomes and complications of immediate (within 24 hours) small-gauge (23-gauge, 25-gauge) pars plana vitrectomy (PPV) for all causes of exogenous endophthalmitis. Methods: A retrospective case series was evaluated. Results: The study included 107 patients who had immediate PPV for exogenous endophthalmitis between 2016 and 2022. The primary outcome measures were the change from baseline best-corrected visual acuity (BCVA) to the final follow-up and the complications after PPV. Causes of exogenous endophthalmitis included intravitreal injections (62.6%), PPV (18.7%), cataract surgery (11.2%), glaucoma surgery (5.6%), and trauma (1.9%). The most common complications were retinal detachment (17.8%) and secondary glaucoma (9.3%). The mean logMAR BCVA improved significantly from the initial diagnosis to the final follow-up (2.26 vs 1.21) ( P\u2009&lt;\u2009.0001). Conclusions: In most cases, immediate small-gauge vitrectomy for exogenous endophthalmitis leads to an improvement in VA, regardless of the VA at presentation. Patients should be counseled about the potential risks associated with PPV surgery.<\/jats:p>","DOI":"10.1177\/24741264241275246","type":"journal-article","created":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T07:58:39Z","timestamp":1726127919000},"page":"694-698","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":7,"title":["Unified Approach to Treating Exogenous Endophthalmitis With Immediate Vitrectomy"],"prefix":"10.1177","volume":"8","author":[{"given":"Graeme K.","family":"Loh","sequence":"first","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, University of Alberta, Edmonton, AB, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit V.","family":"Mishra","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, University of Alberta, Edmonton, AB, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Seamone","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, University of Alberta, Edmonton, AB, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Tennant","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, University of Alberta, Edmonton, AB, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2024,9,11]]},"reference":[{"key":"bibr1-24741264241275246","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1995.01100120009001"},{"key":"bibr2-24741264241275246","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics12081246"},{"key":"bibr3-24741264241275246","doi-asserted-by":"publisher","DOI":"10.1016\/s0008-4182(02)80041-2"},{"key":"bibr4-24741264241275246","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2020-316846"},{"key":"bibr5-24741264241275246","doi-asserted-by":"publisher","DOI":"10.1080\/09273948.2020.1826539"},{"key":"bibr6-24741264241275246","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-005-0082-8"},{"key":"bibr7-24741264241275246","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2006.01.009"},{"key":"bibr8-24741264241275246","doi-asserted-by":"publisher","DOI":"10.3341\/kjo.2022.0014"},{"key":"bibr9-24741264241275246","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-021-05071-w"},{"key":"bibr10-24741264241275246","doi-asserted-by":"publisher","DOI":"10.1016\/j.aopr.2021.100008"},{"key":"bibr11-24741264241275246","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics11010009"},{"key":"bibr12-24741264241275246","doi-asserted-by":"publisher","DOI":"10.1186\/s40942-015-0010-y"}],"container-title":["Journal of VitreoRetinal Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/24741264241275246","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/24741264241275246","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/24741264241275246","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T15:24:22Z","timestamp":1790695462000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/24741264241275246"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,11]]},"references-count":12,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["10.1177\/24741264241275246"],"URL":"https:\/\/doi.org\/10.1177\/24741264241275246","relation":{},"ISSN":["2474-1264","2474-1272"],"issn-type":[{"value":"2474-1264","type":"print"},{"value":"2474-1272","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,11]]}}}